Further analysis revealed that the loss of invasive proteolysis-dependent migration capacity of glioma cells with knockdown of SOX2 could be compensated by a shift to amoeboid migration governed by increased RhoA/ROCK2 signaling. This evidence concerns the gene RHOA and glioma.